Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Riassunto 
Michael Thomas Heffernan is an entrepreneur and businessperson who founded 5 companies, including: Collegium Pharmaceutical, Inc., Avenge Bio, Inc. and PreCision Dermatology, Inc. and who has been at the head of 9 different companies. Presently, he is Chairman for Collegium Pharmaceutical, Inc. (which he founded in 2002), Chairman at Indalo Therapeutics, Inc., Chairman of Carisma Therapeutics, Inc. and President & Director at Avenge Bio, Inc. (which he founded in 2019). Mr. Heffernan is also on the board of Akebia Therapeutics, Inc., Trevi Therapeutics, Inc., Biohaven Pharmaceutical Holding Co. Ltd. and Synlogic, Inc.

He previously occupied the position of Principal at Eli Lilly & Co., Chairman of Veloxis Pharmaceuticals A, Chairman at Astellas Institute for Regenerative Medicine, President & Chief Executive Officer of Clinical Studies Ltd. (he founded the company in 1995), President, Chief Executive Officer & Director at Phymatrix Corp., President & Chief Executive Officer for Onset Dermatologics LLC (he founded the company in 2005) and Director at PreCision Dermatology, Inc.

He received an undergraduate degree from the University of Connecticut.


Posti e reponsabilitÓ di Michael Thomas Heffernan 
NomeTitolo Da
Biohaven Pharmaceutical Holding Company Ltd.
(Biotecnologia)
Independent Director 2020
Collegium Pharmaceutical, Inc.
(Prodotti farmaceutici)
Chairman 2018
Akebia Therapeutics, Inc.
(Biotecnologia)
Independent Director 2018
Synlogic, Inc.
(Biotecnologia)
Independent Director 2020
Trevi Therapeutics, Inc.
(Biotecnologia)
Independent Director 2017
Indalo Therapeutics, Inc. Chairman 2019
Carisma Therapeutics, Inc. Chairman -
Avenge Bio, Inc. President & Director 2019


Participazioni di Michael Thomas Heffernan 
NomeAzioni%Valorizzazione
Collegium Pharmaceutical, Inc. (COLL)
(Prodotti farmaceutici)
13 9880,039%287 174 USD
Akebia Therapeutics, Inc. (AKBA)
(Biotecnologia)
48 5860,028%142 843 USD
Trevi Therapeutics, Inc. (TRVI)
(Biotecnologia)
6 3510,029%10 543 USD
Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
(Biotecnologia)
00,0000%0 USD


Michael Thomas Heffernan: network personale 
Le notizie pi¨ lette 
15/09BRAD SMITH: Microsoft annuncia il riacquisto di azioni fino a 60 miliardi di dollari e aumenta il dividendo
MR
13/09MARTIN SORRELL: S4 Capital di Sorrell alza le prospettive di profitto al 40%
MR
14/09STEPHEN SCHERR: Goldman Sachs nomina Coleman come nuovo CFO, sostituendo Scherr
MR
08/09MICHAEL O'LEARY: Ryanair, aeroporti britannici in difficoltà a Natale - O'Leary
RE
09/09FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone arrotonda quota a 6,1%
RE
17/09LEONARDO DEL VECCHIO: Generali, Caltagirone e Del Vecchio cercano alleati, non vogliono Opa
RE
15/09FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone aumenta quota di ulteriore 0,11%, sale sopra 6%
RE
14/09VINCENT BOLLORÉ: Bolloré avrà quota Universal da 5,9 mld euro dopo quotazione
RE
Pi¨ notizie


© 2021 People and Ownership :   
Michael Thomas Heffernan : connessioni